Ian H. Kratter

598 total citations
17 papers, 317 citations indexed

About

Ian H. Kratter is a scholar working on Neurology, Neurology and Pharmacology. According to data from OpenAlex, Ian H. Kratter has authored 17 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Neurology and 5 papers in Pharmacology. Recurrent topics in Ian H. Kratter's work include Transcranial Magnetic Stimulation Studies (7 papers), Neurological disorders and treatments (6 papers) and Treatment of Major Depression (5 papers). Ian H. Kratter is often cited by papers focused on Transcranial Magnetic Stimulation Studies (7 papers), Neurological disorders and treatments (6 papers) and Treatment of Major Depression (5 papers). Ian H. Kratter collaborates with scholars based in United States, France and United Kingdom. Ian H. Kratter's co-authors include Nolan Williams, Steven Finkbeiner, Alice Lau, Wan Song, Gillian P. Bates, Dimitri Krainc, Annie Vogel Ciernia, Adam Labadorf, László Bodai and Christopher A. Ross and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Ian H. Kratter

16 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian H. Kratter United States 9 173 156 70 56 47 17 317
Maria De Risi Italy 10 100 0.6× 75 0.5× 83 1.2× 66 1.2× 41 0.9× 14 342
Agnes A. Luty Australia 4 142 0.8× 115 0.7× 131 1.9× 58 1.0× 49 1.0× 4 343
Monica L. Berlanga United States 9 229 1.3× 280 1.8× 78 1.1× 75 1.3× 20 0.4× 9 453
Marja Koskuvi Finland 6 122 0.7× 89 0.6× 71 1.0× 17 0.3× 122 2.6× 16 322
Shuta Tomisato Japan 5 152 0.9× 115 0.7× 19 0.3× 58 1.0× 15 0.3× 13 308
Alexander J. Sandweiss United States 10 168 1.0× 115 0.7× 34 0.5× 51 0.9× 11 0.2× 20 312
Agnieszka Skalecka Poland 7 147 0.8× 129 0.8× 23 0.3× 22 0.4× 22 0.5× 9 352
Irene Oh United States 9 155 0.9× 114 0.7× 27 0.4× 53 0.9× 30 0.6× 13 330
Kavitha Abiraman United States 8 126 0.7× 158 1.0× 16 0.2× 56 1.0× 52 1.1× 9 341
José Luis Etcheverry Argentina 13 182 1.1× 223 1.4× 187 2.7× 28 0.5× 33 0.7× 26 366

Countries citing papers authored by Ian H. Kratter

Since Specialization
Citations

This map shows the geographic impact of Ian H. Kratter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian H. Kratter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian H. Kratter more than expected).

Fields of papers citing papers by Ian H. Kratter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian H. Kratter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian H. Kratter. The network helps show where Ian H. Kratter may publish in the future.

Co-authorship network of co-authors of Ian H. Kratter

This figure shows the co-authorship network connecting the top 25 collaborators of Ian H. Kratter. A scholar is included among the top collaborators of Ian H. Kratter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian H. Kratter. Ian H. Kratter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cherian, Kirsten, Jackob N. Keynan, Randi Brown, et al.. (2024). Magnesium–ibogaine therapy in veterans with traumatic brain injuries. Nature Medicine. 30(2). 373–381. 22 indexed citations
2.
3.
Bandeira, Igor D., Jason Tucciarone, Ian H. Kratter, et al.. (2024). 273. Comparing the Antisuicidal and Antidepressant Effects of Intravenous Ketamine in Major Depressive Episodes With Suicidal Ideation. Biological Psychiatry. 95(10). S211–S211.
4.
Benrimoh, David, Azeezat Azeez, Jean-Marie Batail, et al.. (2024). Early differences in lassitude predicts outcomes in Stanford Neuromodulation Therapy for difficult to treat depression. SHILAP Revista de lepidopterología. 3(1). 49–49. 1 indexed citations
5.
Kratter, Ian H., et al.. (2024). Sustained Efficacy of Stanford Neuromodulation Therapy (SNT) in Open-Label Repeated Treatment. American Journal of Psychiatry. 181(1). 71–73. 8 indexed citations
6.
Rolle, Camarin E., Uros Topalovic, Rajat S. Shivacharan, et al.. (2023). Responsive deep brain stimulation guided by ventral striatal electrophysiology of obsession durably ameliorates compulsion. Neuron. 112(1). 73–83.e4. 21 indexed citations
7.
Mitra, Anish, et al.. (2023). Targeted neurostimulation reverses a spatiotemporal biomarker of treatment-resistant depression. Proceedings of the National Academy of Sciences. 120(21). e2218958120–e2218958120. 30 indexed citations
8.
Sahlem, Gregory L., Nathaniel L. Baker, Brian J. Sherman, et al.. (2023). A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder. Drug and Alcohol Dependence. 254. 111035–111035. 2 indexed citations
9.
Batail, Jean-Marie, Xiaoqian Xiao, Azeezat Azeez, et al.. (2023). Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial. Translational Psychiatry. 13(1). 240–240. 12 indexed citations
10.
11.
Lipski, Witold, et al.. (2021). Lateralized Effect of Thalamic Deep Brain Stimulation Location on Verbal Abstraction. Movement Disorders. 36(8). 1843–1852. 7 indexed citations
12.
Kratter, Ian H., Jordan F. Karp, Yue‐Fang Chang, et al.. (2020). Association of Preoperative Visual Hallucinations With Cognitive Decline After Deep Brain Stimulation for Parkinson’s Disease. Journal of Neuropsychiatry. 33(2). 144–151. 3 indexed citations
13.
Lipski, Witold, et al.. (2020). Anterior Sensorimotor Subthalamic Nucleus Stimulation Is Associated With Improved Voice Function. Neurosurgery. 87(4). 788–795. 10 indexed citations
14.
Kratter, Ian H., Hengameh Zahed, Alice Lau, et al.. (2016). Serine 421 regulates mutant huntingtin toxicity and clearance in mice. Journal of Clinical Investigation. 126(9). 3585–3597. 37 indexed citations
15.
Lee, Jong‐Min, Kyung‐Hee Kim, Aram Shin, et al.. (2015). Sequence-Level Analysis of the Major European Huntington Disease Haplotype. The American Journal of Human Genetics. 97(3). 435–444. 17 indexed citations
16.
Vashishtha, Malini, Christopher Ng, Ferah Yildirim, et al.. (2013). Targeting H3K4 trimethylation in Huntington disease. Proceedings of the National Academy of Sciences. 110(32). E3027–36. 130 indexed citations
17.
Tannaci, J.F., et al.. (2008). Stereoselective macrocyclization through zirconocene-mediated coupling of achiral dialkynes. Chemical Communications. 233–234. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026